Effectiveness and safety of adalimumab biosimilar in patients with inflammatory bowel disease Jaime E. Poquet-Jornet; Ibanez-Sala; Teresa Garrigues-Pelufo; Adrián Munilla-Das; Valdivia-Perez; Francisco Javier Carrera-Hueso;

Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review Octavio Ballesta-López; María Centelles-Oria; María Remedios Marqués-Miñana; Juan Eduardo Megías-Vericat; José Luis Poveda-Andrés;

Serum levels of infliximab and adalimumab are associated with deep remission in inflammatory bowel disease Óscar Pascual-Marmaneu; María D. Belles-Medall; Raúl Ferrando-Piqueres; Pedro Almela-Notari; María Mendoza-Aguilera; Tamara Álvarez-Martín;